Literature DB >> 19913922

Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.

Kishan Kumar Nyati1, Kashi Nath Prasad, Avantika Verma, Aloukick Kumar Singh, Arshi Rizwan, Sushmita Sinha, Vimal Kumar Paliwal, Sunil Pradhan.   

Abstract

Molecular mimicry between Campylobacter jejuni lipopolysaccharide and host gangliosides induces an immune response leading to axonal damage and Guillain-Barré syndrome (GBS). TLR polymorphisms are associated with many autoimmune diseases. The role of the TLR4 gene in GBS susceptibility largely remains unknown. We investigated TLR4 polymorphism in GBS. One hundred and twenty GBS patients and 150 healthy controls were included. TLR4 (Asp299Gly and Thr399Ile) genes were studied by PCR-RFLP. TLR4 (Asp299Gly) polymorphism was significantly associated with GBS (p, 0.045; OR, 8.75; 95% CI, 1.05-72.88); only acute motor axonal neuropathy (AMAN) was associated with Gly299Gly homozygote (p, 0.027; OR, 12.40; 95% CI, 1.33-115.77) and Thr399Ile (p, 0.019; OR, 3.42; 95% CI, 1.22-9.54) heterozygote, and TLR4-399Ile allele (p, 0.045; OR, 2.63; 95% CI, 1.02-6.75) compared to controls. In conclusion, TLR4 (Asp299Gly) polymorphism is associated with an increased susceptibility to GBS. Besides Asp299Gly, AMAN subtype is also associated with Thr399Ile polymorphism. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913922     DOI: 10.1016/j.jneuroim.2009.10.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  18 in total

Review 1.  Adversomics: a new paradigm for vaccine safety and design.

Authors:  Jennifer A Whitaker; Inna G Ovsyannikova; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2015-05-02       Impact factor: 5.217

Review 2.  A review of the role of genetic factors in Guillain-Barré syndrome.

Authors:  Amin Safa; Tahereh Azimi; Arezou Sayad; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2020-10-07       Impact factor: 3.444

3.  Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk.

Authors:  Hong Jiao; Weizhi Wang; Huabing Wang; Yun Wu; Lihua Wang
Journal:  Mol Biol Rep       Date:  2011-05-22       Impact factor: 2.316

4.  Disialogangliosides and TNFα alter gene expression for cytokines and chemokines in primary brain cell cultures.

Authors:  Donna M Byers; John C Gorbet; Louis N Irwin
Journal:  Neurochem Res       Date:  2011-10-01       Impact factor: 3.996

5.  Lack of association of single nucleotide polymorphisms in toll-like receptors 2 and 4 with enthesitis-related arthritis category of juvenile idiopathic arthritis in Indian population.

Authors:  Arpita Myles; Amita Aggarwal
Journal:  Rheumatol Int       Date:  2012-03-28       Impact factor: 2.631

6.  Toll-like receptors TLR4 (Asp299Gly and Thr399Ile) and TLR2 (Arg677Trp and Arg753Gln) gene polymorphisms in end-stage renal disease patients on peritoneal dialysis.

Authors:  Kamini Singh; Kashi Nath Prasad; Priyanka Mishra; Jahanarah Khatoon; Narayan Prasad; Amit Gupta; Janmejai Kumar Srivastava
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

Review 7.  Guillain-Barré syndrome, transverse myelitis and infectious diseases.

Authors:  Yhojan Rodríguez; Manuel Rojas; Yovana Pacheco; Yeny Acosta-Ampudia; Carolina Ramírez-Santana; Diana M Monsalve; M Eric Gershwin; Juan-Manuel Anaya
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 8.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

Review 9.  Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barré syndrome.

Authors:  Kishan Kumar Nyati; Kashi Nath Prasad
Journal:  Mediators Inflamm       Date:  2014-09-22       Impact factor: 4.711

Review 10.  Biomarkers of Guillain-Barré Syndrome: Some Recent Progress, More Still to Be Explored.

Authors:  Ying Wang; Shuang Sun; Jie Zhu; Li Cui; Hong-Liang Zhang
Journal:  Mediators Inflamm       Date:  2015-09-16       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.